Founder and President of Shizim Group, Israel’s leading biomed services and holdings group. During the past 30 years, Mr. Bornstein has played key roles in the Israeli biomed industry. He was the General Manager of Bristol-Myers Squibb (Israel) until 1992; He subsequently founded Pharmateam Ltd. which successfully represented major pharmaceutical companies in Israel until it was sold in 2000, when Mr. Bornstein founded Shizim Ltd. and through it all its subsidiaries.
On a national level, Mr. Bornstein served as the Biotechnology Committee Chairman of United States-Israel Science & Technology Commission (USISTC) and has founded major organizations including ILSI (Israel Life Science Industry Organization) and ITTN (Israel Technology Transfer Organization). He is a Committee Member at The Life Science Forum of IPCC – the Israeli-Palestinian Chamber of Commerce, and has also served as a member of the Advisory Board – Life Science Industry, The Israel Export & International Cooperation Institute. Mr. Yossi Bornstein is a Director and an Executive Board Member of the Non-Profit organization Israeli MakersTM.